About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

Heart Failure and Cardiac Rehabilitation

Published:

23 September 2022

Citation:

Cardiac Failure Review 2022;8:e28.

AF Ablation in HFpEF

Published:

14 September 2022

Citation:

Arrhythmia & Electrophysiology Review 2022;11:e18.

ATLAS: What do the Superiority Results Mean for S-ICD Therapy?

Published:

05 September 2022

Citation:

Arrhythmia & Electrophysiology Review 2022;11(Suppl 1):1–7.

Adverse Cardiac Effects of SARS-CoV-2 Infection

Published:

01 September 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e19.